Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Tamoxifen citrate 20mg tablets (Wockhardt)
Section 19A approved medicine
(Approval lapsed) Tamoxifen citrate 20mg tablets (Wockhardt)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 517
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
GENRX TAMOXIFEN tamoxifen 20mg (as citrate) tablet bottle - ARTG 153122
TAMOSIN tamoxifen 20mg (as citrate) tablet - ARTG 43527
TAMOXIFEN SANDOZ tamoxifen 20mg (as citrate) tablet blister pack - ARTG 80076
GENOX 20 tamoxifen 20mg (as citrate) tablet blister pack - ARTG 40065
NOLVADEX-D Tamoxifen 20mg (as citrate) tablet blister pack - ARTG 11232
TAMOSIN tamoxifen 20mg (as citrate) tablet - ARTG 43527
TAMOXIFEN SANDOZ tamoxifen 20mg (as citrate) tablet blister pack - ARTG 80076
GENOX 20 tamoxifen 20mg (as citrate) tablet blister pack - ARTG 40065
NOLVADEX-D Tamoxifen 20mg (as citrate) tablet blister pack - ARTG 11232
Indication(s)
Tamoxifen citrate 20mg tablets (Wockhardt) is indicated for the treatment of breast cancer and the primary prevention of breast cancer in women at moderate or high risk